issued
on 12 Dec 2023
Last Applicant/ Owned by
139 Main Street, Suite 500
Cambridge
MA
02142
Serial Number
97690153 filed on 23rd Nov 2022
Registration Number
N/A
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
"BIO"
"BIO" Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopRead More
Gene therapy products, namely, genetically engineered tissues for transplant purposes; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, antivirals; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Anti-cancer preparations; Biological preparations for the treatment of cancer; Digestives for pharmaceutical purposes; Drug delivery agents in the form of a capsule, pill, or liquid that facilitate the delivery of pharmaceutical preparations; Medical preparations for the treatment of cancer, cystic fibrosis, heart disease, and AIDS; Medicinal infusions for treating Cancer, cystic fibrosis, heart disease, and AIDS; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for the treatment and prevention of Cancer, cystic fibrosis, heart disease, and AIDS; Pharmaceutical products for the prevention and treatment of cancer; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Therapeutic pharmaceutical for the treatment of Cancer, cystic fibrosis, heart disease, and AIDS; Unit dose capsules sold empty for pharmaceutical use
No 97690153
No Service/Collective Mark
No
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 12th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 17th Oct 2023 | PUBLISHED FOR OPPOSITION |
| 17th Oct 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 27th Sep 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 11th Sep 2023 | EXAMINERS AMENDMENT -WRITTEN |
| 11th Sep 2023 | EXAMINERS AMENDMENT E-MAILED |
| 11th Sep 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 11th Sep 2023 | EXAMINER'S AMENDMENT ENTERED |
| 11th Sep 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 16th Aug 2023 | ASSIGNED TO EXAMINER |
